|
GOLGA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.292600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.971800E-01 |
| Normal-vs-Stage2 |
8.862200E-01 |
| Normal-vs-Stage3 |
8.167800E-02 |
| Normal-vs-Stage4 |
6.013200E-01 |
| Stage1-vs-Stage2 |
9.740000E-01 |
| Stage1-vs-Stage3 |
5.030400E-02 |
| Stage1-vs-Stage4 |
5.647000E-01 |
| Stage2-vs-Stage3 |
1.701550E-01 |
| Stage2-vs-Stage4 |
7.063000E-01 |
| Stage3-vs-Stage4 |
4.163200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.374200E-01 |
| Normal-vs-AfricanAmerican |
4.444200E-01 |
| Normal-vs-Asian |
4.305800E-01 |
| Caucasian-vs-AfricanAmerican |
4.952800E-01 |
| Caucasian-vs-Asian |
3.533600E-01 |
| AfricanAmerican-vs-Asian |
5.196000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.006600E-01 |
| Normal-vs-Female |
7.598400E-02 |
| Male-vs-Female |
4.274300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.615400E-01 |
| Normal-vs-Extreme_Weight |
6.098400E-01 |
| Normal-vs-Obese |
1.702010E-01 |
| Normal-vs-Extreme_Obese |
1.983020E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.727200E-01 |
| Normal_Weight-vs-Obese |
3.960600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.302600E-01 |
| Extreme_Weight-vs-Obese |
7.777700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.604000E-01 |
| Obese-vs-Extreme_Obese |
1.621970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.154360E-01 |
| Normal-vs-Age(41-60Yrs) |
8.419500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.782200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.083000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.137600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.880300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.136500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.501500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.215800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.340200E-01 |
| Normal-VS-Type2 PRCC |
5.789000E-01 |
| Normal-VS-KIRP CIMP |
7.838400E-02 |
| Normal-VS-Unclassified PRCC |
8.806000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.295200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.636300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.271200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.902100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.213200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.173700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.169200E-01 |
| Normal-vs-N1 |
7.844500E-03 |
| Normal-vs-N2 |
1.202870E-03 |
| N0-vs-N1 |
1.676590E-03 |
| N0-vs-N2 |
9.339700E-02 |
| N1-vs-N2 |
1.184260E-02 |
|
|
